Orphanet: TARGET: A prospective randomised controlled trial of thiopurine methyltransferase TPMT genotyping in the management of patients, prior to commencement of azathioprine treatment Phase IV
x

Search for a clinical trial

* (*) mandatory field

TARGET: A prospective randomised controlled trial of thiopurine methyltransferase (TPMT) genotyping in the management of patients, prior to commencement of azathioprine treatment (Phase IV)

  • Type of clinical trial : Protocol clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Lgc limited - dept of health
  • Website
    • Phase : IV
  • Principal investigator of clinical trial

  • Pr William OLLIER
  • Nowgen - A Centre for Genetics in Healthcare
  • 29 Grafton Street
  • MANCHESTER M13 9WU
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)161 276 5956
  • Fax  : 44 (0)161 276 4058
  • Website
Last update: October 2012

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.